Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Correlation Between the Amplitude of Ankle Dorsiflexion and Occurrence of Patellofemoral Pain Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03213015
Recruitment Status : Completed
First Posted : July 11, 2017
Last Update Posted : July 13, 2017
Sponsor:
Information provided by (Responsible Party):
Filipe Abdalla dos Reis, Universidade Anhanguera

Brief Summary:
The aim of this study was to verify the clinical reliability of ankle dorsiflexion range of motion (ADROM) measurement with weight bearing (WB) using an app on the smartphone (iHand) and to verify if there is correlation between the limitation of the ADROM and the PFP.

Condition or disease Intervention/treatment Phase
Patellofemoral Pain Syndrome Diagnostic Test: Ankle dorsiflexion measurement Not Applicable

Detailed Description:
The change in lower extremity movement pattern has been previously associated with severe knee disorders, including anterior cruciate ligament rupture, patellar tendinopathy, iliotibial band syndrome, and patellofemoral pain (PFP). The aim of this study was to verify the clinical reliability of ankle dorsiflexion range of motion (ADROM) measurement with weight bearing (WB) using an app on the smartphone (iHand) and to verify if there is correlation between the limitation of the ADROM and the PFP.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 67 participants
Intervention Model: Sequential Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Correlation Between the Amplitude of Ankle Dorsiflexion and Occurrence of Patellofemoral Pain Syndrome
Actual Study Start Date : January 25, 2017
Actual Primary Completion Date : March 25, 2017
Actual Study Completion Date : June 30, 2017

Arm Intervention/treatment
Experimental: Experimental
Measurement of ankle dorsiflexion ROM (range of motion) with iHand app (smartphone)
Diagnostic Test: Ankle dorsiflexion measurement
It was used the test with WB, called Lunge Test, in which each evaluator marked a point 15 cm distal to the anterior tuberosity of the tibia (TAT) with a felt tip pen. After that the smartphone (app iHand) will be placed at this point. Between each measurement, the mark was removed with alcohol 70% The demarcated point served as a guide for positioning the smartphone. In order to standardize the smartphone positioning, BHome (home button on the iPhone), was aligned with the TAT pen mark. To ensure the same distance from the foot to the test, the distance of the hallux to the wall was measured (tape measure), recorded and reused for each test.




Primary Outcome Measures :
  1. Ankle Dorsiflexion Degrees [ Time Frame: 1 day ]
    We will evaluate the ankle range of motion (dorsiflexion) with app (iHand) in smartphone. The measurement will be in degree.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 55 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • volunteers with a history of patelofemoral pain
  • presence of image (lesion) in cartilage tissue in Nuclear Magnetic Resonance
  • knee dynamic valgus during the single leg squat test and step down test (clinical tests)

Exclusion Criteria:

  • acute knee lesion
  • acute ankle lesion
  • surgical procedures before six months ago

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03213015


Locations
Layout table for location information
Brazil
Filipe Abdalla
Campo Grande, Mato Grosso do Sul, Brazil, 79117504
Sponsors and Collaborators
Filipe Abdalla dos Reis

Publications of Results:
Layout table for additonal information
Responsible Party: Filipe Abdalla dos Reis, Principal Investigator and Clinical Professor, Universidade Anhanguera
ClinicalTrials.gov Identifier: NCT03213015     History of Changes
Other Study ID Numbers: 2.128.451
First Posted: July 11, 2017    Key Record Dates
Last Update Posted: July 13, 2017
Last Verified: July 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Filipe Abdalla dos Reis, Universidade Anhanguera:
confiability
ankle
patellofemoral pain syndrome

Additional relevant MeSH terms:
Layout table for MeSH terms
Syndrome
Somatoform Disorders
Patellofemoral Pain Syndrome
Disease
Pathologic Processes
Mental Disorders
Joint Diseases
Musculoskeletal Diseases